๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Monoclonal antibodies in the study and therapy of hematopoietic cancers

โœ Scribed by Dana C Matthews; Franklin O Smith; Irwin D Bernstein

Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
904 KB
Volume
4
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

โœฆ Synopsis

Recent advances utilizing monoclonal antibodies to phenotype acute leukemias have revealed no prognostic significance of the expression of lymphoid-associated antigens by acute myeloid leukemia blasts and conflicting results regarding 'biphenotypic' acute myeloid leukemia. Several studies treating patients with refractory lymphoma with immunotoxins reported encouraging results but significant production of anti-mouse or anti-toxin antibody. Radiolabeled antibodies that react with panhematopoietic antigens have delivered selective radiation to marrow, spleen and lymph nodes in animal models and are being used in Phase I studies of marrow transplantation for acute leukemia.

๐Ÿ“œ SIMILAR VOLUMES

Current applications of monoclonal antib
Current applications of monoclonal antibodies for the therapy of hematopoietic cancers
โœ David A. Scheinberg ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 803 KB

Recent trials of monoclonal antibodies in patients with leukemias or lymphomas have demonstrated the remarkable potency of these agents to kill tumor cells specifically and safely. New molecular biological and radiochemical techniques are also allowing rapid inroads into the remaining obstacles to t

Use of syngeneic monoclonal antibodies i
Use of syngeneic monoclonal antibodies in the therapy of disseminated myeloid leukemic cells
โœ D. Berends; A. H. Mulder; G. van Houwelingen; N. J. de Both ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 653 KB

A syngeneic monoclonal antibody (MAb) (IC5F5) was SUC-in RPMI 1640 + 10% fetal calf serum (Seromed, Miles, Brus-cessfully used in the immunotherapy of Rauxher-virus-in-sels). duced myeloid leukemic RMB-I cells. It is directed to a virusencoded, but aberrantly processed protein, which is expressed Mi

Infectious complications of monoclonal a
Infectious complications of monoclonal antibodies used in cancer therapy : A systematic review of the evidence from randomized controlled trials
โœ Petros I. Rafailidis; Ourania K. Kakisi; Konstantinos Vardakas; Matthew E. Falag ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

## Abstract The introduction of monoclonal antibodies (MoAbs) into the treatment of cancer has led to improvements in patient survival. However, to the authors' knowledge, little attention has been paid to the infectious complications associated with their use. The authors performed a systematic re